Original paper
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
Abstract
Moving to multigene testing for all women with breast cancer (BC) could identify many more mutation carriers who can benefit from precision prevention. However, the cost-effectiveness of this approach remains unaddressed.To estimate incremental lifetime effects, costs, and cost-effectiveness of multigene testing of all patients with BC compared with the current practice of genetic testing (BRCA) based on family history (FH) or clinical...
Paper Details
Title
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
Published Date
Dec 1, 2019
Journal
Volume
5
Issue
12
Pages
1718 - 1718
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History